Armata Pharmaceuticals Inc

ASE:ARMP   2:38:02 PM EDT
4.53
+0.32 (+7.47%)
Earnings Announcements

Armata Pharma Reports Q4 And Full Year 2021 Results

Published: 03/17/2022 20:19 GMT
Armata Pharmaceuticals Inc (ARMP) - Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update.
Armata Pharmaceuticals Inc - Qtrly Loss per Share $0.23.
Armata Pharmaceuticals Inc Says Qtrly Grant Revenues $989,000 Versus $504,000.
Revenue is expected to be $1.13 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $1.13 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.